Evaluation of circulating tumor cells in stage III colorectal cancer patients under three or six months of adjuvant therapy.

被引：0
|
作者：
Messaritakis, Ippokratis
Koulouridi, Asimina
Sfakianaki, Maria
Vogiatzoglou, Konstantinos
Gouvas, Nikolaos
Tsiaousis, Ioannis
Athanasakis, Elias
Xynos, Evangelos
Sougklakos, Ioannis
Boukovinas, Ioannis
机构：
[1] Univ Crete, Sch Med, Lab Translat Oncol, Iraklion, Greece
[2] Univ Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
[3] Univ Crete, Dept Translat Oncol, Iraklion, Greece
[4] Univ Cyprus, Nikosia, Cyprus
[5] Univ Crete, Iraklion, Greece
[6] Univ Hosp Heraklion, Iraklion, Greece
[7] Creta Interclin Hosp, Iraklion, Greece
[8] Univ Heraklion, Iraklion, Greece
[9] Bioclin Thessaloniki, Thessaloniki, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15601
引用
收藏
页码：E15601 / E15601
页数：1
相关论文
共 50 条
  • [41] Circulating tumor DNA analysis predicting recurrence risk in patients with stage I-III colorectal cancer
    Gu, J.
    Lei, F.
    Wang, X.
    Huang, W.
    He, X.
    Hong, Y.
    Zeng, Q.
    Wang, Y.
    Gao, Q.
    Niu, P.
    Huang, D.
    Gao, Z.
    Ding, C.
    Zhai, Z.
    An, K.
    Chen, H.
    Zhao, X.
    Chen, S.
    Bai, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S561 - S561
  • [42] Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (07): : 481 - 481
  • [43] Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
    Tie, Jeanne
    Cohen, Joshua D.
    Lahouel, Kamel
    Lo, Serigne N.
    Wang, Yuxuan
    Kosmider, Suzanne
    Wong, Rachel
    Shapiro, Jeremy
    Lee, Margaret
    Harris, Sam
    Khattak, Adnan
    Burge, Matthew
    Harris, Marion
    Lynam, James
    Nott, Louise
    Day, Fiona
    Hayes, Theresa
    McLachlan, Sue-Anne
    Lee, Belinda
    Ptak, Janine
    Silliman, Natalie
    Dobbyn, Lisa
    Popoli, Maria
    Hruban, Ralph
    Lennon, Anne Marie
    Papadopoulos, Nicholas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Tomasetti, Cristian
    Gibbs, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : 2261 - 2272
  • [44] Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
    Akagunduz, Baran
    Guven, Deniz Can
    Ozer, Muhammet
    Okten, Ilker Nihat
    Atag, Elif
    Unek, Ilkay Tugba
    Tatli, Ali Murat
    Karaoglu, Aziz
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (02)
  • [45] The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials
    Cascinu, S.
    Poli, D.
    Zaniboni, A.
    Lonardi, S.
    Labianca, R.
    Sobrero, A.
    Rosati, G.
    Di Bartolomeo, M.
    Scartozzi, M.
    Zagonel, V.
    Pella, N.
    Banzi, M.
    Torri, V.
    EUROPEAN JOURNAL OF CANCER, 2019, 111 : 1 - 7
  • [46] Prognostic value of circulating tumor DNA (ctDNA) detection during adjuvant chemotherapy in patients with stage III colorectal cancer: The interim report of a prospective, observational study
    Peng, Junjie
    Li, Yaqi
    Mo, Shaobo
    Ma, Xiaoji
    Hu, Xiang
    Zhang, Long
    Huang, Dan
    Cai, Sanjun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [47] Evaluation of circulating tumor cells in colorectal cancer using flow cytometry
    Musina, Ana-Maria
    Zlei, Mihaela
    Mentel, Mihaela
    Scripcariu, Dragos-Viorel
    Stefan, Madalina
    Anitei, Maria-Gabriela
    Filip, Bogdan
    Radu, Iulian
    Gavrilescu, Mihaela-Madalina
    Panuta, Andrian
    Buna-Arvinte, Mihaela
    Cordun, Cristiana-Ioana
    Predescu, Dragos-Valentin
    Scripcariu, Viorel
    Hutanu, Ionut
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (09)
  • [48] Evaluation of the EPISPOT assay in circulating tumor cells detection and prognostication in metastatic colorectal cancer patients
    Mazard, Thibault
    Cayrefourcq, Laure
    Assenat, Eric
    Senellart, Helene
    de la Fouchardiere, Christelle
    Linot, Benjamin
    Francois, Eric
    Terrebonne, Eric
    Obled, Stephane
    Guimbaud, Rosine
    Mineur, Laurent
    Becouarn, Yves
    Duval, Julie
    Perriard, Francoise
    Daures, Jean Pierre
    Ychou, Marc
    Alix-Panabieres, Catherine
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 177 - 177
  • [49] Three versus six months adjuvant oxaliplatin plus fluoropyrimidine chemotherapy for patients with stage III colon cancer: The Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant (IDEA) chemotherapy project.
    Souglakos, John
    Boukovinas, Ioannis
    Xynogalos, Spyros
    Kakolyris, Stylianos
    Ziras, Nikolaos
    Vaslamatzis, Michael
    Ardavanis, Alexandros
    Athanasiadis, Athanasios
    Androulakis, Nikolaos E. M.
    Kentepozidis, Nikolaos K.
    Christopoulou, Athina
    Makrantonakis, Paris
    Varthalitis, Ioannis I.
    Christofyllakis, Charalampos
    Emmanouilides, Christos E.
    Mavroudis, Dimitrios
    Prinarakis, Efthimios
    Kalisperi, Aggeliki
    Hatzidaki, Dora
    Georgoulias, Vassilis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [50] Impact of circulating tumor DNA on clinical decisions in the adjuvant setting in patients with colorectal cancer
    Wookey, V.
    Mehler, S.
    Stein, M.
    Grothey, A.
    Norton, A.
    Somer, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S139 - S139
12345